Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca
Alliance for Clinical Trials in Oncology
Hoffmann-La Roche
Novartis
BioNumerik Pharmaceuticals, Inc.
NSABP Foundation Inc
Uppsala University
ChineseAMS
Mayo Clinic
Medifocus, Inc.
University College, London
Nova Scotia Health Authority